KALA BIO, Inc.
Income Statement
| Line Item | FY2016 | FY2015 |
|---|---|---|
| Revenue | $0 | $45.0K |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $25.0M | $11.4M |
| SG&A Expense | $7.6M | $4.6M |
| Operating Income | $-32.7M | $-15.9M |
| Operating Margin | — | -35,435.6% |
| Interest Expense | $767.0K | $604.0K |
| Pretax Income | — | — |
| Income Tax Expense | $0 | — |
| Net Income | $-33.2M | $-16.7M |
| Net Margin | — | -37,071.1% |
| EPS (Basic) | $-14.04 | $-7.45 |
| EPS (Diluted) | $-14.04 | $-7.45 |
| Shares Outstanding (Basic) | 2.4M | — |
| Shares Outstanding (Diluted) | 2.4M | — |
| Dividends Per Share | — | — |